Page last updated: 2024-08-24

3-iodobenzylguanidine and Conus Medullaris Syndrome

3-iodobenzylguanidine has been researched along with Conus Medullaris Syndrome in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Galbavy, S; Kokavec, M; Svec, A; Zamborsky, R	1
Clement, SC; Kraal, KC; Kremer, LC; Tytgat, GA; van den Bos, C; van Eck-Smit, BL; van Santen, HM	1
Andrade, MQ; Castro Júnior, DO; Feitosa, AC; Moura, M; Rocha Filho, J; Sanches, A	1
Blin, V; Enon, B; Picquet, J; Rohmer, V	1
Ball, AB; Fisher, C; Harmer, CL; Sinnett, HD; Tait, DM	1

Reviews

1 review(s) available for 3-iodobenzylguanidine and Conus Medullaris Syndrome

Article	Year
Bone metastases in neuroendocrine tumors. Bratislavske lekarske listy, 2017, Volume: 118, Issue:9 Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Cancer Pain; Chromogranin A; Diphosphonates; Fractures, Spontaneous; Humans; Hypercalcemia; Neuroendocrine Tumors; Radiotherapy; Somatostatin; Spinal Cord Compression; Surgical Procedures, Operative	2017

Article

Year

Bone metastases in neuroendocrine tumors.

Bratislavske lekarske listy, 2017, Volume: 118, Issue:9

Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Cancer Pain; Chromogranin A; Diphosphonates; Fractures, Spontaneous; Humans; Hypercalcemia; Neuroendocrine Tumors; Radiotherapy; Somatostatin; Spinal Cord Compression; Surgical Procedures, Operative

2017

Other Studies

4 other study(ies) available for 3-iodobenzylguanidine and Conus Medullaris Syndrome

Article	Year
Primary ovarian insufficiency in children after treatment with 131I-metaiodobenzylguanidine for neuroblastoma: report of the first two cases. The Journal of clinical endocrinology and metabolism, 2014, Volume: 99, Issue:1 Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child; Female; Humans; Iodine Radioisotopes; Neuroblastoma; Primary Ovarian Insufficiency; Radiation Injuries; Spinal Cord Compression; Spinal Neoplasms	2014
Spinal cord compression after radiolabeled metaiodobenzylguanidine analogue therapy in advanced malignant insulinoma. Archives of endocrinology and metabolism, 2015, Volume: 59, Issue:2 Topics: 3-Iodobenzylguanidine; Aged; Bone Neoplasms; Combined Modality Therapy; Fatal Outcome; Female; Humans; Insulinoma; Liver Neoplasms; Lymphatic Metastasis; Pancreatic Neoplasms; Radiopharmaceuticals; Spinal Cord Compression	2015
[Secreting paraganglioma of the organ of Zuckerkandl. A case report]. Journal des maladies vasculaires, 2002, Volume: 27, Issue:4 Topics: 3-Iodobenzylguanidine; Back Pain; Catecholamines; Combined Modality Therapy; Diagnostic Imaging; Hemangioma; Humans; Iodine Radioisotopes; Laminectomy; Lumbar Vertebrae; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Multiple Primary; Para-Aortic Bodies; Paraganglioma; Radioisotope Teletherapy; Radiotherapy, Adjuvant; Retroperitoneal Neoplasms; Spinal Cord Compression; Spinal Neoplasms; Thoracic Vertebrae; Vascular Neoplasms; Vena Cava, Inferior	2002
Treatment of metastatic para-aortic paraganglioma by surgery, radiotherapy and I-131 mIBG. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 1991, Volume: 17, Issue:5 Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Combined Modality Therapy; Humans; Iodine Radioisotopes; Iodobenzenes; Laminectomy; Male; Middle Aged; Para-Aortic Bodies; Paraganglioma; Spinal Cord Compression; Spinal Neoplasms; Sympatholytics	1991